- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 317/26 - Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
Patent holdings for IPC class C07D 317/26
Total number of patents in this class: 62
10-year publication summary
|
8
|
1
|
6
|
3
|
2
|
1
|
3
|
2
|
4
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Syngenta Limited | 448 |
3 |
| Ambrx, Inc. | 183 |
3 |
| 3m Innovative Properties Company | 17771 |
2 |
| BASF SE | 21017 |
2 |
| Merck Sharp & Dohme Corp. | 2190 |
2 |
| Firmenich SA | 1699 |
2 |
| Givaudan SA | 1893 |
2 |
| M2I Development | 5 |
2 |
| Reata Pharmaceuticals, Inc. | 117 |
2 |
| Stichting voor de Technische Wetenschappen | 113 |
2 |
| UMC Utrecht Holding B.V. | 211 |
2 |
| Universiteit Utrecht Holding B.V. | 139 |
2 |
| M2I Salin | 2 |
2 |
| MSD R & D (China) Co. LTD. | 56 |
2 |
| Structure Holdings LLC | 2 |
2 |
| AstraZeneca AB | 2886 |
1 |
| Syngenta Participations AG | 1833 |
1 |
| Massachusetts Institute of Technology | 10115 |
1 |
| Sumitomo Chemical Company, Limited | 9079 |
1 |
| Agricultural Research Council | 23 |
1 |
| Other owners | 25 |